{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:05:18Z","timestamp":1792785918689,"version":"4.5.0"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"R1","license":[{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL051670"],"award-info":[{"award-number":["HL051670"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL91842"],"award-info":[{"award-number":["HL91842"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL123482"],"award-info":[{"award-number":["HL123482"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011352","name":"University of Iowa Center for Gene Therapy","doi-asserted-by":"crossref","award":["DK54759"],"award-info":[{"award-number":["DK54759"]}],"id":[{"id":"10.13039\/100011352","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Roy J. Carver Chair in Molecular Medicine"},{"name":"Roy J. Carver Chair in Pulmonary Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cystic fibrosis (CF) is a multiorgan recessive genetic disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Gene therapy efforts have focused on treating the lung, since it manifests the most significant life-threatening disease. Over two decades have past since the first CF lung gene therapy trials and significant advances in the therapeutic implementation of pharmacologic CFTR modulators have renewed the field's focus on developing gene therapies for the 10% of CF patients these modulators cannot help. This review summarizes recent progress made in developing vectors for airway transduction and CF animal models required for understanding the relevant cellular targets in the lung and testing the efficacy of gene therapy approaches. We also highlight future opportunities in emerging gene editing strategies that may offer advantages for treating diseases like CF where the gene target is highly regulated at the cellular level. The outcomes of CF lung gene therapy trials will likely inform productive paths toward gene therapy for other complex genetic disorders, while also advancing treatments for all CF patients.<\/jats:p>","DOI":"10.1093\/hmg\/ddz139","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T07:18:50Z","timestamp":1563520730000},"page":"R88-R94","source":"Crossref","is-referenced-by-count":93,"title":["Advances in gene therapy for cystic fibrosis lung disease"],"prefix":"10.1093","volume":"28","author":[{"given":"Ziying","family":"Yan","sequence":"first","affiliation":[{"name":"Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B","family":"McCray Jr","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Pappajohn Biomedical Institute, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2389-9277","authenticated-orcid":false,"given":"John F","family":"Engelhardt","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,7,23]]},"reference":[{"key":"2019101710390719800_ref1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"2019101710390719800_ref2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11130","article-title":"Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung","volume":"487","author":"Pezzulo","year":"2012","journal-title":"Nature"},{"key":"2019101710390719800_ref3","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jcf.2017.09.003","article-title":"Progress in understanding mucus abnormalities in cystic fibrosis airways","volume":"17","author":"Wine","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"2019101710390719800_ref4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.coph.2018.09.007","article-title":"The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis","volume":"43","author":"Shei","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"2019101710390719800_ref5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jtbi.2017.11.010","article-title":"An integrated mathematical epithelial cell model for airway surface liquid regulation by mechanical forces","volume":"438","author":"Wu","year":"2018","journal-title":"J. Theor. Biol."},{"key":"2019101710390719800_ref6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/sj.ejhg.5200158","article-title":"Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis","volume":"6","author":"Jiang","year":"1998","journal-title":"Eur. J. Hum. Genet."},{"key":"2019101710390719800_ref7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMra1300109","article-title":"Origins of cystic fibrosis lung disease","volume":"372","author":"Stoltz","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2019101710390719800_ref8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jcf.2018.05.004","article-title":"CFTR modulator theratyping: current status, gaps and future directions","volume":"18","author":"Clancy","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"2019101710390719800_ref9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S2213-2600(14)70132-8","article-title":"A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial","volume":"2","author":"Boyle","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"2019101710390719800_ref10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-Ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2019101710390719800_ref11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"2019101710390719800_ref12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nbt.4068","article-title":"Fresh from the biotech pipeline-2017","volume":"36","author":"Morrison","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"2019101710390719800_ref13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0092-8674(93)80063-K","article-title":"Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis","volume":"75","author":"Zabner","year":"1993","journal-title":"Cell"},{"key":"2019101710390719800_ref14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/hum.1994.5.4-501","article-title":"Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: a phase I trial","volume":"5","author":"Wilson","year":"1994","journal-title":"Hum. Gene Ther."},{"key":"2019101710390719800_ref15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/hum.1995.6.2-205","article-title":"Adenovirus-mediated gene transfer for cystic fibrosis: part a. Safety of dose and repeat administration in the nasal epithelium. Part B. Clinical efficacy in the maxillary sinus","volume":"6","author":"Welsh","year":"1995","journal-title":"Hum. Gene Ther."},{"key":"2019101710390719800_ref16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJM199509283331302","article-title":"A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis","volume":"333","author":"Knowles","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"2019101710390719800_ref17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ng0994-42","article-title":"Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis","volume":"8","author":"Crystal","year":"1994","journal-title":"Nat. Genet."},{"key":"2019101710390719800_ref18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/hum.1995.6.5-643","article-title":"A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung","volume":"6","author":"Crystal","year":"1995","journal-title":"Hum. Gene Ther."},{"key":"2019101710390719800_ref19","first-page":"615","article-title":"Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity","volume":"5","author":"Boucher","year":"1994","journal-title":"The University of North Carolina at Chapel Hill. Hum. Gene Ther."},{"key":"2019101710390719800_ref20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-2600(15)00245-3","article-title":"Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial","volume":"3","author":"Alton","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"2019101710390719800_ref21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/genes10030218","article-title":"Lentiviral vectors for the treatment and prevention of cystic fibrosis lung disease","volume":"10","author":"Marquez Loza","year":"2019","journal-title":"Genes (Basel)"},{"key":"2019101710390719800_ref22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/humc.2018.081","article-title":"Long-term follow-up of a phase I\/II study of ProSavin, a lentiviral vector gene therapy for Parkinson's disease","volume":"29","author":"Palfi","year":"2018","journal-title":"Hum. Gene Ther. Clin. Dev"},{"key":"2019101710390719800_ref23","doi-asserted-by":"crossref","first-page":"12818","DOI":"10.1128\/JVI.79.20.12818-12827.2005","article-title":"Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer","volume":"79","author":"Sinn","year":"2005","journal-title":"J. Virol."},{"key":"2019101710390719800_ref24","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1128\/JVI.66.11.6829-6835.1992","article-title":"Baculovirus gp64 envelope glycoprotein is sufficient to mediate pH-dependent membrane fusion","volume":"66","author":"Blissard","year":"1992","journal-title":"J. Virol."},{"key":"2019101710390719800_ref25","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2012.60","article-title":"Intrapulmonary versus nasal transduction of murine airways with GP64-pseudotyped viral vectors","volume":"2","author":"Oakland","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2019101710390719800_ref26","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88730","article-title":"Lentiviral-mediated phenotypic correction of cystic fibrosis pigs","volume":"1","author":"Cooney","year":"2016","journal-title":"JCI Insight"},{"key":"2019101710390719800_ref27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1089\/humc.2014.154","article-title":"Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy","volume":"26","author":"Yan","year":"2015","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"2019101710390719800_ref28","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/gt.2017.78","article-title":"Novel GP64 envelope variants for improved delivery to human airway epithelial cells","volume":"24","author":"Sinn","year":"2017","journal-title":"Gene Ther."},{"key":"2019101710390719800_ref29","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/mt.2010.13","article-title":"Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with Sendai virus envelopes","volume":"18","author":"Mitomo","year":"2010","journal-title":"Mol. Ther."},{"key":"2019101710390719800_ref30","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1164\/rccm.201206-1056OC","article-title":"Assessment of F\/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy","volume":"186","author":"Griesenbach","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2019101710390719800_ref31","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/MCP.0000000000000327","article-title":"Cystic fibrosis gene therapy: a mutation-independent treatment","volume":"22","author":"Griesenbach","year":"2016","journal-title":"Curr. Opin. Pulm. Med."},{"key":"2019101710390719800_ref32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/thoraxjnl-2016-208406","article-title":"Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis","volume":"72","author":"Alton","year":"2017","journal-title":"Thorax"},{"key":"2019101710390719800_ref33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/jgm.1368","article-title":"Single-dose lentiviral gene transfer for lifetime airway gene expression","volume":"11","author":"Stocker","year":"2009","journal-title":"J. Gene Med."},{"key":"2019101710390719800_ref34","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.1128\/JVI.00227-08","article-title":"Lentivirus vector can be readministered to nasal epithelia without blocking immune responses","volume":"82","author":"Sinn","year":"2008","journal-title":"J. Virol."},{"key":"2019101710390719800_ref35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/jgm.2695","article-title":"High efficiency gene transfer to airways of mice using influenza hemagglutinin pseudotyped lentiviral vectors","volume":"15","author":"Patel","year":"2013","journal-title":"J. Gene Med."},{"key":"2019101710390719800_ref36","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1172\/JCI118573","article-title":"Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis","volume":"97","author":"Zabner","year":"1996","journal-title":"J Clin. Invest."},{"key":"2019101710390719800_ref37","doi-asserted-by":"crossref","first-page":"10219","DOI":"10.1074\/jbc.274.15.10219","article-title":"Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia","volume":"274","author":"Walters","year":"1999","journal-title":"J. Biol. Chem."},{"key":"2019101710390719800_ref38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/mthe.2000.0244","article-title":"Host responses and persistence of vector genome following intrabronchial administration of an E1(\u2212)E3(\u2212) adenovirus gene transfer vector to normal individuals","volume":"3","author":"Harvey","year":"2001","journal-title":"Mol. Ther."},{"key":"2019101710390719800_ref39","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.4049\/jimmunol.180.6.4098","article-title":"Characterization of pulmonary T cell response to helper-dependent adenoviral vectors following intranasal delivery","volume":"180","author":"Kushwah","year":"2008","journal-title":"J Immunol"},{"key":"2019101710390719800_ref40","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/hum.2017.201","article-title":"Transducing airway basal cells with a helper-dependent adenoviral vector for lung gene therapy","volume":"29","author":"Cao","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"2019101710390719800_ref41","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.1093\/nar\/gky773","article-title":"Widespread airway distribution and short-term phenotypic correction of cystic fibrosis pigs following aerosol delivery of piggyBac\/adenovirus","volume":"46","author":"Cooney","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"2019101710390719800_ref42","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1089\/hum.2007.022","article-title":"Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial","volume":"18","author":"Moss","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"2019101710390719800_ref43","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/sj.mt.6300277","article-title":"Biological differences in rAAV transduction of airway epithelia in humans and in Old World non-human primates","volume":"15","author":"Liu","year":"2007","journal-title":"Mol. Ther."},{"key":"2019101710390719800_ref44","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1172\/JCI8317","article-title":"Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus","volume":"105","author":"Duan","year":"2000","journal-title":"J. Clin. Invest."},{"key":"2019101710390719800_ref45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1089\/hum.2015.001","article-title":"Optimization of recombinant adeno-associated virus-mediated expression for large transgenes using a synthetic promoter and tandem array enhancers","volume":"26","author":"Yan","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"2019101710390719800_ref46","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1073\/pnas.0409845102","article-title":"A shortened adeno-associated virus expression cassette for CFTR gene transfer to cystic fibrosis airway epithelia","volume":"102","author":"Ostedgaard","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2019101710390719800_ref47","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1073\/pnas.0813365106","article-title":"Directed evolution of adeno-associated virus to an infectious respiratory virus","volume":"106","author":"Excoffon","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2019101710390719800_ref48","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1038\/mt.2013.92","article-title":"A novel chimeric adenoassociated virus 2\/human bocavirus 1 parvovirus vector efficiently transduces human airway epithelia","volume":"21","author":"Yan","year":"2013","journal-title":"Mol. Ther."},{"key":"2019101710390719800_ref49","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1089\/hum.2018.173","article-title":"Establishment of a high-yield recombinant adeno-associated virus\/human bocavirus vector production system independent of bocavirus nonstructural proteins","volume":"30","author":"Yan","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"2019101710390719800_ref50","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1089\/hum.2017.060","article-title":"Human bocavirus type-1 capsid facilitates the transduction of ferret airways by adeno-associated virus genomes","volume":"28","author":"Yan","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"2019101710390719800_ref51","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.jcf.2017.09.001","article-title":"Animal and model systems for studying cystic fibrosis","volume":"17","author":"Rosen","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"2019101710390719800_ref52","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1165\/rcmb.2013-0261OC","article-title":"Lung phenotype of juvenile and adult cystic fibrosis transmembrane conductance regulator-knockout ferrets","volume":"50","author":"Sun","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2019101710390719800_ref53","doi-asserted-by":"crossref","first-page":"29ra31","DOI":"10.1126\/scitranslmed.3000928","article-title":"Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth","volume":"2","author":"Stoltz","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"2019101710390719800_ref54","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.ajpath.2014.01.035","article-title":"Gastrointestinal pathology in juvenile and adult CFTR-knockout ferrets","volume":"184","author":"Sun","year":"2014","journal-title":"Am. J. Pathol."},{"key":"2019101710390719800_ref55","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1126\/science.1163600","article-title":"Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs","volume":"321","author":"Rogers","year":"2008","journal-title":"Science"},{"key":"2019101710390719800_ref56","doi-asserted-by":"crossref","first-page":"e88728","DOI":"10.1172\/jci.insight.88728","article-title":"CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes","volume":"1","author":"Steines","year":"2016","journal-title":"JCI Insight"},{"key":"2019101710390719800_ref57","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1172\/JCI68867","article-title":"Intestinal CFTR expression alleviates meconium ileus in cystic fibrosis pigs","volume":"123","author":"Stoltz","year":"2013","journal-title":"J. Clin. Invest."},{"key":"2019101710390719800_ref58","doi-asserted-by":"crossref","first-page":"eaau7531","DOI":"10.1126\/scitranslmed.aau7531","article-title":"In utero and postnatal VX-770 administration rescues multiorgan disease in a ferret model of cystic fibrosis","volume":"11","author":"Sun","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"2019101710390719800_ref59","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ng1192-240","article-title":"Submucosal glands are the predominant site of CFTR expression in the human bronchus","volume":"2","author":"Engelhardt","year":"1992","journal-title":"Nat. Genet."},{"key":"2019101710390719800_ref60","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1172\/JCI117028","article-title":"Expression of the cystic fibrosis gene in adult human lung","volume":"93","author":"Engelhardt","year":"1994","journal-title":"J. Clin. Invest."},{"key":"2019101710390719800_ref61","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41586-018-0393-7","article-title":"A revised airway epithelial hierarchy includes CFTR-expressing ionocytes","volume":"560","author":"Montoro","year":"2018","journal-title":"Nature"},{"key":"2019101710390719800_ref62","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41586-018-0394-6","article-title":"A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte","volume":"560","author":"Plasschaert","year":"2018","journal-title":"Nature"},{"key":"2019101710390719800_ref63","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"2019101710390719800_ref64","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"2019101710390719800_ref65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat. Med."},{"key":"2019101710390719800_ref66","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s10038-017-0352-4","article-title":"In vivo genome editing via the HITI method as a tool for gene therapy","volume":"63","author":"Suzuki","year":"2018","journal-title":"J. Hum. Genet."},{"key":"2019101710390719800_ref67","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.tibtech.2018.03.004","article-title":"Strategies for in vivo genome editing in nondividing cells","volume":"36","author":"Nami","year":"2018","journal-title":"Trends Biotechnol."},{"key":"2019101710390719800_ref68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncb3452","article-title":"The control of DNA repair by the cell cycle","volume":"19","author":"Hustedt","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"2019101710390719800_ref69","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"key":"2019101710390719800_ref70","doi-asserted-by":"crossref","first-page":"L231","DOI":"10.1152\/ajplung.90209.2008","article-title":"Ciliated epithelial cell lifespan in the mouse trachea and lung","volume":"295","author":"Rawlins","year":"2008","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/advance-article-pdf\/doi\/10.1093\/hmg\/ddz139\/29093745\/ddz139.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/28\/R1\/R88\/30160319\/ddz139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/28\/R1\/R88\/30160319\/ddz139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T07:23:14Z","timestamp":1610522594000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/28\/R1\/R88\/5537028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,23]]},"references-count":70,"journal-issue":{"issue":"R1","published-online":{"date-parts":[[2019,7,23]]},"published-print":{"date-parts":[[2019,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddz139","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10]]},"published":{"date-parts":[[2019,7,23]]}}}